Antibacterial activity of bovine lactoferrin-derived peptides

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 54-59

  Hoek, Keith S ^a,b   Milne, Joanne M ^a   Grieve, Paul A ^a   Dionysius, David A ^a   Smith, Ross ^b  

^a DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; GROWTH INHIBITION; IRON BINDING CAPACITY; MYELOPOIESIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE HOMOLOGY; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CATTLE; CHYMOSIN; CYANOGEN BROMIDE; HYDROGEN-ION CONCENTRATION; LACTOFERRIN; MERCAPTOETHANOL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 0031037469     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Abe, H., H. Saito, H. Miyakawa, Y. Tamura, S. Shimamura, E. Nagao, and M. Tomita. 1991. Heat stability of bovine lactoferrin at acidic pH. J. Dairy Sci. 74:65-71.
2. Allan, G. 1989. Sequencing of proteins and peptides, p. 95-99. In R. H. Burdon and P. H. Van Knippenberg (ed.), Laboratory techniques in biochemistry and molecular biology, vol. 9, 2nd ed. Elsevier, Amsterdam, The Netherlands.
3. Anderson, B. F., H. M. Baker, G. E. Norris, D. W. Rice, and E. N. Baker. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 Å resolution. J. Mol. Biol. 209:711-734.
4. Arnold, R. R., J. E. Russell, W. J. Champion, M. Brewer, and J. J. Gauthier. 1982. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect. Immun. 35:792-799.
5. Batish, V. K., H. Chander, K. C. Zumdegni, K. L. Bhatia, and R. S. Singh. 1088. Antibacterial activity of lactoferrin against some common food-borne pathogenic organisms. Aust. J. Dairy Technol. 43:16-18.
6. Bellamy, W., M. Takase, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73:472-479.
7. Bellamy, W., M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121:130-136.
8. Bellamy, W., H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita. 1993. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182:97-105.
9. Bellamy, W., K. Yamauchi, H. Wakabayashi, M. Takase, N. Takakura, S. Shimamura, and M. Tomita. 1994. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett. Appl. Microbiol. 18:230-233.
10. Bennett, R. M., and T. Kokocinski. 1979. Lactoferrin turnover in man. Clin. Sci. 57:453-460.
11. Brock, J. H., F. Arzabe, F. Lampreave, and A. Piñeiro. 1976. The effect of trypsin on bovine transferrin and lactoferrin. Biochim. Biophys. Acta 446: 214-225.
12. Brock, J. H., A. Piñeiro, and F. Lampreave. 1978. The effect of trypsin and chymotrypsin on the antibacterial activity of complement, antibodies and lactoferrin and transferrin in bovine colostrum. Ann. Rech. Vet. 9:287-294.
13. Broxmeyer, H. E., and E. Platzer. 1984. Lactoferrin acts on I-A and I-E/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit productions of GM-CSF in vitro. J. Immunol. 133:306-313.
14. Bullen, J. J., H. J. Rogers, and L. Leigh. 1972. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br. Med. J. 1:69-75.
15. Delfour, A., J. Jollés, C. Alais, and P. Jollés. 1965. Caseinoglycopeptides: characterisation of a methionine residue and of the N-terminal sequence. Biochem. Biophys. Res. Commun. 19:452-455.
16. Dionysius, D. A., J. B. Herse, and P. A. Grieve. 1991. Extraction of lactoperoxidase and lactoferrin from whey using batch ion exchange techniques. Aust. J. Dairy Technol. 46:72-76.
17. Dionysius, D. A., P. A. Grieve, and J. M. Milne. 1993. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J. Dairy Sci. 76:2597-2606.
18. Ellison, R. T., III, and T. J. Giehl. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88:1080-1091.
19. Ellison, R. T., III, T. J. Giehl, and F. M. LaForce. 1988. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56:2774-2781.
20. Galbraith, P. R. 1986. Effects of lactoferrin on human granulopoiesis in vitro. Clin. Invest. Med. 9:1-5.
21. Gu, T., G. T. Tsao, G. Tsai, and M. R. Ladisch. 1990. Displacement effect in multicomponent chromatography. Adv. Chem. Eng. J. 36:1156-1162.
22. Hutchens, T. W., J. F. Henry, and T. Yip. 1989. Purification and characterization of intact lactoferrin found in the urine of human milk-fed preterm infants. Clin. Chem. 35:1928-1933.
23. Larrick, J. W., M. Hirata, Y. Shimomoura, M. Yoshida, H. Zheng, J. Zhong, and S. C. Wright. 1993. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob. Agents Chemother. 37:2534-2539.
24. Law, B. A., and B. Reiter. 1977. The isolation and bacteriostatic properties of lactoferrin from bovine milk whey. J. Dairy Res. 44:595-599.
25. Legrand, D., J. Mazurier, A. Elass, E. Rochard, G. Vergoten, P. Maes, J. Montreuil, and G. Spik. 1992. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry 31:9243-9251.
26. Leveugle, B., J. Mazurier, D. Legrand, C. Mazurier. J. Montreuil, and G. Spik. 1993. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem. 213:1205-1211.
27. Masson P. L., J. F. Heremans, and C. Dive. 1966. An iron-binding protein common to many external secretions. Clin. Chim. Acta 14:735-739.
28. Mazover E., S. Levy-Toledano, F. Rendu, L. Hermant, H. Lu, A. M. Fiat, P. Jolles, and J. Caen. 1990. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur. J. Biochem. 194:43-49.
29. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
30. Nonnecke, B. J., and K. L. Smith. 1984. Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth. J. Dairy Sci. 67:606-613.
31. Ofek, I., S. Cohen, R. Rahmani, K. Kabha, D. Tamarkin, Y. Herzig, and E. Rubinstein. 1994. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob. Agents Chemother. 38:374-377.
32. Oram, J. D., and B. Reiter. 1968. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim. Biophys. Acta 170:351-365.
33. Oseas, R., H. H. Yang, R. L. Baehner, and L. A. Boxer. 1981. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood 57:939-945.
34. Pierce A., D. Colavizza, M. Benaissa, P. Maes, A. Tartar, J. Montreuil, and G. Spik. 1991. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem. 196:177-184.
35. Saito, H., H. Miyakawa, Y. Tamura, S. Shimamura, and M. Tomita. 1991. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH. J. Dairy Sci. 74:3724-3730.
36. Schroder, G., K. Brandenburg, and U. Seydel. 1992. Polymyxin B induces transient permeability fluctuations in an asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry 31:631-638.
37. Shimazaki, K., S. Nagata, and Y. C. Yoo. 1991. Susceptibility of bovine lactoferrin to plasmin and chymosin. Agric. Biol. Chem. 56:1125-1126.
38. Todhunter, D., K. L. Smith, and J. S. Hogan. 1990. Growth of gram-negative bacteria in dry cow secretion. J. Dairy Sci. 73:363-372.
39. Tomita, M. 1994. Active peptides of lactoferrin, p. 7-13. In Proceedings of the International Dairy Federation Seminar. Indigenous antimicrobial agents of milk: recent developments.
40. Tomita, M., W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi, and K. Kawase. 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74:4137-4142.
41. Uchida Y., and M. Shindo. 1992. Synthesis and antibacterial activity of a novel antibiotic, bactenecin, and related peptides. Bull. Chem. Soc. Jpn.
42. Van Snick, J. L., B. Markowetz, and P. L. Masson. 1977. The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin. J. Exp. Med. 146:817-827.
43. Van Snick, J. L., P. L. Masson, and J. F. Heremans. 1974. The involvement of lactoferrin in the hyposideremia of acute inflammation. J. Exp. Med. 140:1068-1084.
44. Wakabayashi, H., W. Bellamy, M. Takase, and M. Tomita. 1992. Inactivation of Listeria monocytogenes by lactoferricin, a potent antimicrobial peptide derived from cow's milk. J. Food Prot. 55:238-240.
45. Ward, P. P., C. S. Piddington, G. A. Cunningham, X. Zhou, R. D. Wyatt, and O. M. Conneely. 1995. A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Bio/Technology 13: 498-503.
46. Wu, G., C. Ruan, L. Drouet, and J. Caen. 1992. Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. Haemostasis 22:1-6.
47. Yamauchi, K., M. Tomita, T. J. Giehl, and R. T. Ellison III. 1993. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61:719-728.
48. Ziere, G. J., M. K. Bijsterbosch, and T. J. C. Van Berkel. 1993. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of β-very low density lipoprotein binding. J. Biol. Chem. 268:27069-27075.